Genetic Information is Irrelevant to Most People's Care
By Press Release,
GeneWatch UK
| 06. 04. 2014
GeneWatch UK today criticised a speech by the new NHS England Chief Executive Simon Stevens, in which he reportedly argued that the NHS must be transformed to make people's personal genetic information the basis of their treatments (1).
"Stevens appears shockingly ignorant of the irrelevance of genetic information to most people's care" said Dr Helen Wallace, Director of GeneWatch UK, "Plans to sequence everybody's genomes in the NHS are driven by commercial interests and are not in the public interest".
Successive governments have made attempts to build a DNA database in the NHS in England by stealth, by sequencing every baby at birth and storing whole genomes in electronic medical records, a plan backed by Health Secretary Jeremy Hunt (2). The current version of this plan would involve sharing whole or partial DNA sequences (genomes or genotypes) with companies like Google, which would use genetic information and health data to calculate personal risk assessments for feedback to patients (3). Massive investment from taxpayers would be required as part of a public-private partnership that allowed commercial exploitation...
Related Articles
By Darren Incorvaia, Fierce Biotech | 07.16.2026
Jennifer Doudna, Ph.D., the Nobel Laureate best known for co-inventing the CRISPR system that has become the foundation for gene editing, is dipping her toes into a new, buzzy field: AI-powered protein design.
In a new paper, published today...
By Risa Cromer, The Conversation | 07.17.2026
By Emily Packard Dawson and Lainie Friedman Ross , The Hastings Center for Bioethics | 07.16.2026
Major news outlets recently reported – based on a bioRxiv preprint – that scientists had edited genes in human embryos with “startling precision.” The scientists’ decision to release this work ahead of peer review, coupled with the extensive media coverage...
Media coverage of recent developments in embryo gene editing might seem to suggest that gene-edited babies are close to becoming a reality. As tech billionaires eager to profit off of techno-eugenics invest in “designer baby” technologies, attempts to normalize heritable genome editing – which remains unsafe and raises significant ethical and societal concerns – are especially dangerous. It’s worth taking a closer look at these developments and what they mean, in a way that pushes back on narratives normalizing the...